Shantha Biotechnics
Indian biotechnology company and vaccine manufacturer
Shantha Biotechnics Limited is an Indian biotechnology company headquartered in Hyderabad, India. It is the first Indian company to develop, manufacture, and market recombinant human healthcare products in India. The company is a wholly owned subsidiary of the Sanofi group.
Shantha Biotechnics caters to major international markets including Asia-Pacific, Africa, Commonwealth of Independent States, and Latin America in addition to international organisations UNICEF and PAHO.
History
Shantha Biotechnics, Ltd. began with the initiatives of Dr. K. I. Varaprasad Reddy. Varaprasad established the company in 1993 to produce affordable drugs for the general population, while maintaining international standards in quality. The project originated as an R&D project at Osmania University under the industry-university interactive programme in 1993, and later operated from the Center for Cellular and Molecular Biology until an independent research and development facility was built.
In 2006, the European biotech major Mérieux Alliance bought a 60% stake in Shantha Biotechnics at a valuation of $175 million.
In 2009, the vaccine division of French pharmaceutical company Sanofi Pasteur acquired the stake held by Mérieux Alliance, valuing Shantha Biotech at Euro 550 million (over Rs 3,770 crore).
“Shantha Biotechnics” enters the record as indian biotechnology company and vaccine manufacturer. Crown Archives preserves that source wording while asking what Shantha, Biotechnics and Indian can confirm, complicate or overturn.
Why this record matters
“Shantha Biotechnics” is worth following because a concise public description often conceals a longer documentary argument. Here, Shantha, Biotechnics and Indian provides the most credible route into that argument.
Contemporary correspondence, administrative files and participant testimony can test how later narratives organized the event or institution. The source revision retrieved here is dated Aug 11, 2026. The linked authority identifier is Q7489045. 2 of 2 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 1993, 2006 and 2009.
Later summaries often reconcile disputed chronology or motive more neatly than the contemporary record permits. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Compare institutional narratives with records created by participants and affected communities. Dates and formal titles are useful anchors, but not substitutes for context.
- Event chronology
- Institutional context
- Locating named record creators
Contemporary correspondence, government or organizational records, oral histories and cited historical scholarship.
Three-step research path
- Establish the record: confirm the title “Shantha Biotechnics”, its source revision and the description used here.
- Expand the search: follow Shantha Biotechnics primary sources, Shantha Biotechnics archive and Shantha research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Shantha Biotechnics”?
- What chronology connects this entry to wider political or social change?
- Which voices are present, absent or mediated by the institution?
Search terms from this dossier
This entry incorporates text from “Shantha Biotechnics” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.